Valuation & Scoring
Does the remaining patent term affect its value?
The short answer
Directly — remaining term defines how many years of royalty income or exclusivity a buyer is purchasing. Academic value studies deliberately analyze full-term patent cohorts because expiring patents lose their tail value almost entirely; practitioners discount steeply once fewer than about five years remain.
The full picture
The math is unforgiving: a license is a claim on future royalties, and a patent with three years left has three years of royalties to sell. Buyers price accordingly. Remaining term also shapes strategy — long remaining life favors patient licensing campaigns; short remaining life favors fast sales or aggressive licensing to incumbents already shipping.
Two nuances worth knowing: patent term adjustments and extensions can add time in specific cases, and a patent family with live continuations can extend effective coverage well beyond the first patent's expiry. If your term clock is ticking, the window to monetize is now — and it's shorter than it feels. Worth a conversation before another year rolls off.
Where does your patent stand?
The Beyond the Patent Commercialization Score answers that — a professional, factor-by-factor read on your patent's licensing, sale, build, and partner potential.
Related questions
General information for patent owners — not legal advice. Read the disclaimer.